Published in Neurobiol Aging on April 28, 2008
BRI2 protein regulates β-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE). J Biol Chem (2011) 1.47
Kisspeptin prevention of amyloid-β peptide neurotoxicity in vitro. ACS Chem Neurosci (2012) 0.83
Glycosylation of BRI2 on asparagine 170 is involved in its trafficking to the cell surface but not in its processing by furin or ADAM10. Glycobiology (2011) 0.79
Benzothiazole aniline tetra(ethylene glycol) and 3-amino-1,2,4-triazole inhibit neuroprotection against amyloid peptides by catalase overexpression in vitro. ACS Chem Neurosci (2013) 0.77
The Familial British Dementia Mutation Promotes Formation of Neurotoxic Cystine Cross-linked Amyloid Bri (ABri) Oligomers. J Biol Chem (2015) 0.76
Lessons from a Rare Familial Dementia: Amyloid and Beyond. J Parkinsons Dis Alzheimers Dis (2015) 0.76
Dimerization of cell surface receptors in signal transduction. Cell (1995) 6.58
Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron (1996) 5.14
Palmitoylation of ligands, receptors, and intracellular signaling molecules. Sci STKE (2006) 3.56
Folding of helical membrane proteins: the role of polar, GxxxG-like and proline motifs. Curr Opin Struct Biol (2004) 3.42
Multisubunit assembly of an integral plasma membrane channel protein, gap junction connexin43, occurs after exit from the ER. Cell (1993) 3.33
Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci (2005) 2.63
A stop-codon mutation in the BRI gene associated with familial British dementia. Nature (1999) 2.46
A model for central synaptic junctional complex formation based on the differential adhesive specificities of the cadherins. Neuron (1996) 2.20
Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J Biol Chem (1996) 2.17
APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos. Proc Natl Acad Sci U S A (2002) 2.16
A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci U S A (2000) 2.11
Homo- and heterodimerization of APP family members promotes intercellular adhesion. EMBO J (2005) 1.98
Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease. J Biol Chem (2001) 1.96
A presenilin dimer at the core of the gamma-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis. Proc Natl Acad Sci U S A (2003) 1.92
The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production. J Biol Chem (2005) 1.67
BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer. Trends Biochem Sci (2002) 1.66
Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia. Nat Neurosci (1999) 1.53
Identification and molecular characterization of m3 muscarinic receptor dimers. J Biol Chem (1999) 1.51
BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production. J Biol Chem (2005) 1.48
Identification of the intermolecular disulfide bonds of the human transferrin receptor and its lipid-attachment site. EMBO J (1987) 1.48
Identification of the cysteine residues in the amino-terminal extracellular domain of the human Ca(2+) receptor critical for dimerization. Implications for function of monomeric Ca(2+) receptor. J Biol Chem (1999) 1.24
A conserved GXXXG motif in APH-1 is critical for assembly and activity of the gamma-secretase complex. J Biol Chem (2003) 1.19
Familial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan AND A{beta}) in the absence of compact plaques. J Biol Chem (2005) 1.18
Axonal transport of British and Danish amyloid peptides via secretory vesicles. FASEB J (2003) 1.17
Mechanism of transmembrane signaling: insulin binding and the insulin receptor. Biochemistry (2000) 1.12
Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain. Acta Neuropathol (2003) 1.10
Dimerization of beta-site beta-amyloid precursor protein-cleaving enzyme. J Biol Chem (2004) 1.05
Mutational analysis of the cysteines in the extracellular domain of the human Ca2+ receptor: effects on cell surface expression, dimerization and signal transduction. FEBS Lett (1998) 1.04
Disulfide bonds in the extracellular calcium-polyvalent cation-sensing receptor correlate with dimer formation and its response to divalent cations in vitro. J Biol Chem (1998) 1.03
Cataract, deafness, cerebellar ataxia, psychosis and dementia--a new syndrome. Acta Neurol Scand (1970) 1.02
Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils. J Mol Biol (2001) 1.01
Expression, purification, and biochemical characterization of the amino-terminal extracellular domain of the human calcium receptor. J Biol Chem (1999) 1.01
Oligomerization and neurotoxicity of the amyloid ADan peptide implicated in familial Danish dementia. J Neurochem (2004) 0.99
cDNA sequence analysis, chromosomal assignment and expression pattern of the gene coding for integral membrane protein 2B. Gene (1998) 0.97
Role of extracellular cysteine residues in dimerization/oligomerization of the human prostacyclin receptor. Eur J Pharmacol (2004) 0.93
The extracellular calcium-sensing receptor dimerizes through multiple types of intermolecular interactions. J Biol Chem (2000) 0.93
Systemic amyloid deposits in familial British dementia. J Biol Chem (2001) 0.91
Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion. Prostate (2003) 0.90
Familial Presenile Dementia with Spastic Paralysis. J Neurol Psychopathol (1933) 0.90
Induction of p53-independent apoptosis by the BH3-only protein ITM2Bs. FEBS Lett (2004) 0.90
Expression of mDab1 promotes the stability and processing of amyloid precursor protein and this effect is counteracted by X11alpha. Neurobiol Aging (2006) 0.90
Characterization of the dimerization of metabotropic glutamate receptors using an N-terminal truncation of mGluR1alpha. J Neurochem (1999) 0.88
Dimerization of the calcium-sensing receptor occurs within the extracellular domain and is eliminated by Cys --> Ser mutations at Cys101 and Cys236. J Biol Chem (1999) 0.86
Co-expression of nicastrin and presenilin rescues a loss of function mutant of APH-1. J Biol Chem (2004) 0.82
Expression of mBRI2 in mice. Neurosci Lett (2003) 0.80
ITM2BS regulates apoptosis by inducing loss of mitochondrial membrane potential. Eur J Immunol (2002) 0.78
Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science (2006) 6.47
RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med (2003) 5.14
Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A (2005) 3.91
A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J (2002) 3.87
The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production. J Biol Chem (2005) 1.67
Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol (2009) 1.57
Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol (2003) 1.56
BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production. J Biol Chem (2005) 1.48
Proteomic analysis of exfoliation deposits. Invest Ophthalmol Vis Sci (2007) 1.47
Sporadic and familial cerebral amyloid angiopathies. Brain Pathol (2002) 1.33
Systemic catabolism of Alzheimer's Abeta40 and Abeta42. J Biol Chem (2004) 1.30
Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease. Proc Natl Acad Sci U S A (2010) 1.21
Familial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan AND A{beta}) in the absence of compact plaques. J Biol Chem (2005) 1.18
Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J Neuropathol Exp Neurol (2002) 1.16
Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection. Behav Brain Res (2011) 1.15
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J Neurochem (2003) 1.14
pH-dependent amyloid and protofibril formation by the ABri peptide of familial British dementia. J Mol Biol (2003) 1.10
Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions. Vascul Pharmacol (2002) 1.07
Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme. J Biol Chem (2003) 1.07
Brain clearance of Alzheimer's amyloid-beta40 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy. J Drug Target (2002) 1.06
Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease. J Biol Chem (2002) 1.04
Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease. Neurobiol Aging (2004) 1.03
Dutch and Arctic mutant peptides of beta amyloid(1-40) differentially affect the FGF-2 pathway in brain endothelium. Exp Cell Res (2008) 1.01
Clusterin and Alzheimer's disease. Subcell Biochem (2005) 1.00
Calpastatin modulates APP processing in the brains of β-amyloid depositing but not wild-type mice. Neurobiol Aging (2011) 0.98
Tumoral non-amyloidotic monoclonal immunoglobulin light chain deposits ('aggregoma'): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses. Br J Haematol (2002) 0.97
Cerebral amyloidosis: amyloid subunits, mutants and phenotypes. Cell Mol Life Sci (2009) 0.96
Insulin-degrading enzyme in brain microvessels: proteolysis of amyloid {beta} vasculotropic variants and reduced activity in cerebral amyloid angiopathy. J Biol Chem (2004) 0.93
Expression of mDab1 promotes the stability and processing of amyloid precursor protein and this effect is counteracted by X11alpha. Neurobiol Aging (2006) 0.90
A strategy for designing a peptide probe for detection of β-amyloid oligomers. Chembiochem (2010) 0.89
Brain neprilysin activity and susceptibility to transgene-induced Alzheimer amyloidosis. Neurosci Lett (2005) 0.88
APOE genotype results in differential effects on the peripheral clearance of amyloid-beta42 in APOE knock-in and knock-out mice. J Alzheimers Dis (2010) 0.88
Abeta(1-40)-induced secretion of matrix metalloproteinase-9 results in sAPPalpha release by association with cell surface APP. Neurobiol Dis (2007) 0.87
Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells. J Biol Chem (2010) 0.87
Isolation and biochemical characterization of amyloid plaques and paired helical filaments. Curr Protoc Cell Biol (2009) 0.87
MAL facilitates the incorporation of exocytic uroplakin-delivering vesicles into the apical membrane of urothelial umbrella cells. Mol Biol Cell (2012) 0.87
BRI2 as a central protein involved in neurodegeneration. Biotechnol J (2008) 0.87
Iowa variant of familial Alzheimer's disease: accumulation of posttranslationally modified AbetaD23N in parenchymal and cerebrovascular amyloid deposits. Am J Pathol (2010) 0.86
Preamyloid lesions and cerebrovascular deposits in the mechanism of dementia: lessons from non-beta-amyloid cerebral amyloidosis. Neurodegener Dis (2008) 0.85
Presenilin 1 and cadherins: stabilization of cell-cell adhesion and proteolysis-dependent regulation of transcription. Neurodegener Dis (2004) 0.85
Insulin-degrading enzyme degrades amyloid peptides associated with British and Danish familial dementia. Biochem Biophys Res Commun (2005) 0.84
Assembly of a membrane receptor complex: roles of the uroplakin II prosequence in regulating uroplakin bacterial receptor oligomerization. Biochem J (2008) 0.83
Soluble Abeta homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteins. Neurobiol Aging (2004) 0.83
Human cerebrospinal fluid apolipoprotein E isoforms are apparently inefficient at complexing with synthetic Alzheimer's amyloid-[beta] peptide (A[beta] 1-40 ) in vitro. Mol Med (2002) 0.83
Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-beta levels in female rats. Horm Behav (2008) 0.83
Search for amyloid-binding proteins by affinity chromatography. Methods Mol Biol (2012) 0.82
Notch 1 interacts with the amyloid precursor protein in a Numb-independent manner. J Neurosci Res (2005) 0.82
Profiling brain and plasma lipids in human APOE epsilon2, epsilon3, and epsilon4 knock-in mice using electrospray ionization mass spectrometry. J Alzheimers Dis (2010) 0.82
Clusterin and complement activation in exfoliation glaucoma. Invest Ophthalmol Vis Sci (2014) 0.81
Homer2 and Homer3 interact with amyloid precursor protein and inhibit Abeta production. Neurobiol Dis (2008) 0.81
Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease. J Neurol Sci (2007) 0.81
Differential contribution of isoaspartate post-translational modifications to the fibrillization and toxic properties of amyloid β and the Asn23 Iowa mutation. Biochem J (2013) 0.80
Insights into caspase-mediated apoptotic pathways induced by amyloid-β in cerebral microvascular endothelial cells. Neurodegener Dis (2011) 0.79
Glycosylation of BRI2 on asparagine 170 is involved in its trafficking to the cell surface but not in its processing by furin or ADAM10. Glycobiology (2011) 0.79
PYROGLUTAMATE FORMATION AT THE N-TERMINI OF ABRI MOLECULES IN FAMILIAL BRITISH DEMENTIA IS NOT RESTRICTED TO THE CENTRAL NERVOUS SYSTEM. Hirosaki Igaku (2010) 0.77
CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE. Hirosaki Igaku (2010) 0.76
Downregulation of AβPP enhances both calcium content of endoplasmic reticulum and acidic stores and the dynamics of store operated calcium channel activity. J Alzheimers Dis (2013) 0.76
BRI2 interacts with BACE1 and regulates its cellular levels by promoting its degradation and reducing its mRNA levels. Curr Alzheimer Res (2013) 0.76
An animal model of vascular amyloidosis. Nat Neurosci (2004) 0.75
Novel processing of Notch 1 within its intracellular domain by a cysteine protease. Neurodegener Dis (2007) 0.75
Cell-line specific protection by berry polyphenols against hydrogen peroxide challenge and lack of effect on metabolism of amyloid precursor protein. Phytother Res (2011) 0.75
Radiolabeling of amyloid-beta peptides. Methods Mol Biol (2005) 0.75
Diversity of senile plaques in Alzheimer's disease as revealed by a new monoclonal antibody that recognizes an internal sequence of the Abeta peptide. Curr Alzheimer Res (2005) 0.75